(from application): The central premise underlying the San Antonio Nathan Shock Aging Center described in this proposal is that identifying the biological mechanisms that lead to senescence can best be achieved by manipulating the whole organism genetically, nutritionally, or pharmacologically in ways that modify the aging process rather than by relying on phenomenological studies. Our Center will focus its effort on providing investigators with """"""""state-of-the-art"""""""" scientific infrastructure, resources, and services that can be used in the development and use of rodent models to study pertinent questions on the basic biology of aging. The Center proposed in this application will consist of seven Resource Cores (a Transgenic Core, an Embryonic Stem Cell Core, an Animal Core, a Pathology Core, a Genomic Assessment Core, an Expression Profiling Core, and a Biometry Core), a Research Development Core, and a Program Enrichment Core. The Cores of the Center will provide investigators with resources/services in four areas. First, the Transgenic, Embryonic Stem Cell, and Animal Cores will generate novel rodent models for Center faculty by genetic (transgenic or knockout) procedures or nutritional and pharmacological manipulations. Second, the Animal, Pathology, Genetic Assessment, Expression Profiling, and Biometry Cores will provide Center faculty with the resources/services required to characterize the effect of the various manipulations on aging in rodents. Third, the Research Development Core will provide investigators new to aging research with pilot grants and mentors to develop research programs in aging that are competitive in acquiring extramural funding. Fourth, the Program Enrichment Core will provide an administrative base designed to enhance the research environment in aging in San Antonio and the region and to encourage collaborative research on aging among Center faculty members.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
5P30AG013319-07
Application #
6372055
Study Section
Special Emphasis Panel (ZAG1-PKN-2 (M1))
Program Officer
Sierra, Felipe
Project Start
1995-07-10
Project End
2005-06-30
Budget Start
2001-09-30
Budget End
2002-06-30
Support Year
7
Fiscal Year
2001
Total Cost
$860,819
Indirect Cost
Name
University of Texas Health Science Center San Antonio
Department
Physiology
Type
Other Domestic Higher Education
DUNS #
800772162
City
San Antonio
State
TX
Country
United States
Zip Code
78229
Xu, Ming; Pirtskhalava, Tamar; Farr, Joshua N et al. (2018) Senolytics improve physical function and increase lifespan in old age. Nat Med 24:1246-1256
Unnikrishnan, Archana; Hadad, Niran; Masser, Dustin R et al. (2018) Revisiting the genomic hypomethylation hypothesis of aging. Ann N Y Acad Sci 1418:69-79
Van Skike, Candice E; Jahrling, Jordan B; Olson, Angela B et al. (2018) Inhibition of mTOR protects the blood-brain barrier in models of Alzheimer's disease and vascular cognitive impairment. Am J Physiol Heart Circ Physiol 314:H693-H703
Mao, Kai; Quipildor, Gabriela Farias; Tabrizian, Tahmineh et al. (2018) Late-life targeting of the IGF-1 receptor improves healthspan and lifespan in female mice. Nat Commun 9:2394
Lee, Hak Joo; Feliers, Denis; Barnes, Jeffrey L et al. (2018) Hydrogen sulfide ameliorates aging-associated changes in the kidney. Geroscience 40:163-176
Kang, Donghoon; Kirienko, Daniel R; Webster, Phillip et al. (2018) Pyoverdine, a siderophore from Pseudomonas aeruginosa, translocates into C. elegans, removes iron, and activates a distinct host response. Virulence 9:804-817
Hook, Michael; Roy, Suheeta; Williams, Evan G et al. (2018) Genetic cartography of longevity in humans and mice: Current landscape and horizons. Biochim Biophys Acta Mol Basis Dis 1864:2718-2732
Van Skike, Candice E; Galvan, Veronica (2018) A Perfect sTORm: The Role of the Mammalian Target of Rapamycin (mTOR) in Cerebrovascular Dysfunction of Alzheimer's Disease: A Mini-Review. Gerontology 64:205-211
Kraig, Ellen; Linehan, Leslie A; Liang, Hanyu et al. (2018) A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effects. Exp Gerontol 105:53-69
Ungvari, Zoltan; Tarantini, Stefano; Donato, Anthony J et al. (2018) Mechanisms of Vascular Aging. Circ Res 123:849-867

Showing the most recent 10 out of 231 publications